Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 12:39 AM
NCT ID:
NCT06472167
Eligibility Criteria:
Inclusion Criteria:
* The patients fulfilled the criteria for COPD: the presence of a post bronchodilator FEV1 \< 80% predicated together with an FEV1/FVC \<0.70confirm the presence of airflow limitation that is not fully reversible.
* COPD patients ranging from mild to severe according to GOLD \[stages I-IV\].
* Asthmatic patients receive medical treatment for at least 6 months; and clinically stable (i.e., no exacerbation or changes in medication for ≥30 days).
* None of the individuals had been engaged in any exercise-training program before participating in the study.
* Optimized medical therapy according to GOLD \& Global Initiative for Asthma (GINA)
* Clinically stable COPD and asthmatic patients (not suffering from a recent respiratory tract infection).
* All patients are Ex-smoker
Exclusion Criteria:
* Age \<18 years.
* Pregnancy
* Current Smokers
* Patients that are incapable of exercising; unable to understand any questionnaire
* Multiple co- morbidity (e.g., cardiovascular diseases, active cancer)
* Neuromuscular disease as Myasthenia gravis, kypho-scoliosis
* Diaphragmatic Paralysis (paralyzed diaphragm exhibiting abnormal paradoxical movement, i.e., moving in a cranial direction during inspiration).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06472167
Study Brief:
Protocol Section:
NCT06472167